Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InfuSystem Holdings (INFU) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for InfuSystem Holdings (INFU) over the last 17 years, with Q3 2025 value amounting to $18.7 million.

  • InfuSystem Holdings' Total Current Liabilities rose 1052.2% to $18.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.7 million, marking a year-over-year increase of 1052.2%. This contributed to the annual value of $17.7 million for FY2024, which is 1239.74% up from last year.
  • InfuSystem Holdings' Total Current Liabilities amounted to $18.7 million in Q3 2025, which was up 1052.2% from $15.9 million recorded in Q2 2025.
  • In the past 5 years, InfuSystem Holdings' Total Current Liabilities registered a high of $18.7 million during Q3 2025, and its lowest value of $12.2 million during Q1 2021.
  • Moreover, its 5-year median value for Total Current Liabilities was $14.5 million (2021), whereas its average is $15.1 million.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first plummeted by 4891.17% in 2021, then soared by 2427.85% in 2024.
  • InfuSystem Holdings' Total Current Liabilities (Quarter) stood at $12.9 million in 2021, then increased by 12.18% to $14.5 million in 2022, then grew by 8.61% to $15.7 million in 2023, then grew by 12.4% to $17.7 million in 2024, then grew by 5.98% to $18.7 million in 2025.
  • Its Total Current Liabilities stands at $18.7 million for Q3 2025, versus $15.9 million for Q2 2025 and $16.0 million for Q1 2025.